| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 45 | 624,441 | DNTH, CGON, ORKA, JBIO | 13F-HR | 8/14/2026 | 000179182726000005 |
| Q1 2026 | 45 | 493,809 | DNTH, CGON, ORKA, CATX | NEW HOLDINGS | 5/27/2026 | 000179182726000004 |
| Q1 2026 | 46 | 441,891 | DNTH, ORKA, JBIO, CATX | 13F-HR | 5/13/2026 | 000179182726000003 |
| Q4 2025 | 39 | 346,693 | DNTH, CGON, JBIO, ORKA | 13F-HR | 2/13/2026 | 000179182726000002 |
| Q3 2025 | 43 | 439,394 | DNTH, CGON, MDT, BSX | 13F-HR | 11/14/2025 | 000179182725000008 |
| Q2 2025 | 56 | 501,976 | CGON, BSX, NTRA, DNTH | 13F-HR | 8/14/2025 | 000179182725000007 |
| Q1 2025 | 67 | 524,678 | BSX, DNTH, UNH, CGON | 13F-HR | 5/15/2025 | 000179182725000005 |
| Q4 2024 | 63 | 1,018,174 | DNTH, BSX, JANX, NTRA | 13F-HR | 2/14/2025 | 000179182725000002 |
| Q3 2024 | 81 | 1,960,342 | BSX, DNTH, ISRG, NTRA | 13F-HR | 11/14/2024 | 000179182724000011 |
| Q2 2024 | 85 | 2,353,381 | ISRG, BSX, NTRA, ARVN | 13F-HR | 8/14/2024 | 000179182724000007 |
| Q1 2024 | 90 | 3,101,466 | ITCI calls, FUSN, BSX, ARVN | 13F-HR | 5/15/2024 | 000179182724000004 |
| Q4 2023 | 74 | 2,743,946 | ARVN, BSX, CI calls, TMO | 13F-HR | 2/14/2024 | 000179182724000002 |
| Q3 2023 | 83 | 2,483,190 | BSX, JAZZ, BDX, NBIX | 13F-HR | 11/14/2023 | 000179182723000006 |
| Q2 2023 | 93 | 2,863,157 | BDX, KRTX, JAZZ, GEHC | 13F-HR | 8/14/2023 | 000179182723000004 |
| Q1 2023 | 83 | 3,012,659 | ARVN, SGRY, BIO, ARGX | 13F-HR | 5/15/2023 | 000179182723000003 |
| Q4 2022 | 85 | 4,615,991 | XBI calls, ARGX, UTHR, NBIX | 13F-HR | 2/14/2023 | 000179182723000002 |
| Q3 2022 | 97 | 4,918,761 | LLY, SPDR SER TR calls, UTHR, NBIX | 13F-HR | 11/14/2022 | 000179182722000008 |
| Q2 2022 | 82 | 4,355,880 | AZN, VRTX, ARGX, ELV | 13F-HR | 8/15/2022 | 000179182722000006 |
| Q1 2022 | 92 | 4,802,645 | SPDR SER TR calls, AZN, ABBV, ARVN | 13F-HR | 5/16/2022 | 000179182722000004 |
| Q4 2021 | 97 | 4,714,958 | ABBV, ZNTL, ARVN, AVTR | 13F-HR | 2/14/2022 | 000179182722000002 |
| Q3 2021 | 105 | 4,513,577 | XBI calls, XLRN calls, MRTX, ARVN | 13F-HR | 11/15/2021 | 000179182721000006 |
| Q2 2021 | 112 | 3,699,847 | VRTX, ABBV, ARVN, LLY | 13F-HR | 8/16/2021 | 000179182721000005 |
| Q1 2021 | 94 | 3,619,767 | ABBV, AZN, AVTR, MDT | 13F-HR | 5/17/2021 | 000179182721000004 |
| Q4 2020 | 96 | 3,080,209 | AVTR, ARVN, ABBV, LLY | 13F-HR | 2/16/2021 | 000179182721000002 |
| Q3 2020 | 68 | 2,155,960 | PFIZER INC calls, ABBV, SGEN, AVTR | 13F-HR | 11/16/2020 | 000179182720000006 |
| Q2 2020 | 57 | 1,560,198 | ABBV, REGN, BHVN, BAX | 13F-HR | 8/14/2020 | 000179182720000004 |
| Q1 2020 | 52 | 723,593 | SGEN, MRK, ABBV, MCK | NEW HOLDINGS | 6/17/2020 | 000091957420004168 |
| Q1 2020 | 1 | 0 | 13F-HR | 5/15/2020 | 000091957420003442 | |
| Q4 2019 | 33 | 158,691 | BAX, HCA, VRTX, ABBV | NEW HOLDINGS | 6/17/2020 | 000091957420004167 |
| Q4 2019 | 1 | 0 | 13F-HR | 2/14/2020 | 000091957420001350 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||||
|
Dianthus Therapeutics, Inc.
13D/A
DNTH · 252828108
|
4.9% |
11/19/2025
Event 11/17/2025
|
||||
| Avidity Partners Management LP | 4.9% | |||||
| Avidity Partners Management (GP) LLC | 4.9% | |||||
| Avidity Capital Partners Fund (GP) LP | 4.9% | |||||
| Avidity Capital Partners (GP) LLC | 4.9% | |||||
| Avidity Private Master Fund I LP | 4.4% | |||||
| Michael Gregory | 4.9% | |||||
7 other securities where the latest filing is a 13G, the newest filed 5/12/2026. View all